Ftse Mib
35.138,61
0,98%
DAX
20.271,33
0,67%
S&P 500
5.835,04
-0,02%
NASDAQ
19.126,86
0,20%
Bitcoin
96.537,41
2,15%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Allergy Therapeutics Plc (AGY) Allergy Therapeutics Plc (AGY) Notizie

AGY

Allergy Therapeutics (AGY)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AGY
DataOraFonteTitoloSimboloCompagnia
19/12/202414:41RNS Regulatory NewsAllergy Therapeutics PLC Exercise of Options and Total Voting RightsLSE:AGYAllergy Therapeutics Plc
17/12/202417:19RNS Regulatory NewsAllergy Therapeutics PLC Block Listing Interim ReviewLSE:AGYAllergy Therapeutics Plc
16/12/202416:33RNS Regulatory NewsAllergy Therapeutics PLC Result of Annual General MeetingLSE:AGYAllergy Therapeutics Plc
04/12/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Positive Interim Data from PROTECT TrialLSE:AGYAllergy Therapeutics Plc
27/11/202417:52Alliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics treats first patient in allergy trialLSE:AGYAllergy Therapeutics Plc
27/11/202408:00RNS Regulatory NewsAllergy Therapeutics PLC First Patient Dosed in G308 Paediatric TrialLSE:AGYAllergy Therapeutics Plc
25/11/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Submission of MAA for Grass MATA MPLLSE:AGYAllergy Therapeutics Plc
21/11/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Notice of 2024 Annual General MeetingLSE:AGYAllergy Therapeutics Plc
06/11/202412:22Alliance NewsAlliance NewsAllergy Therapeutics annual loss narrows thanks to reduced expensesLSE:AGYAllergy Therapeutics Plc
06/11/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Audited Preliminary Results 2024LSE:AGYAllergy Therapeutics Plc
21/10/202411:56Alliance NewsAlliance NewsAllergy Therapeutics enrols candidates for grass pollen allergy trialLSE:AGYAllergy Therapeutics Plc
21/10/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Commencement of Phase III Paediatric TrialLSE:AGYAllergy Therapeutics Plc
16/10/202411:58Alliance NewsAlliance NewsAllergy Therapeutics shares surge as enters into secured loan facilityLSE:AGYAllergy Therapeutics Plc
16/10/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
01/10/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Update on funding and preliminary resultsLSE:AGYAllergy Therapeutics Plc
17/09/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Progression of patient cohorts in PROTECT TrialLSE:AGYAllergy Therapeutics Plc
27/08/202410:57Alliance NewsAlliance NewsAllergy Therapeutics secures cash to see it through SeptemberLSE:AGYAllergy Therapeutics Plc
22/07/202417:26Alliance NewsAlliance NewsTRADING UPDATES: Croma Security trading well; Fonix to up final payoutLSE:AGYAllergy Therapeutics Plc
22/07/202408:01RNS Regulatory NewsAllergy Therapeutics PLC Trading update for the year ended 30 June 2024LSE:AGYAllergy Therapeutics Plc
22/07/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Nominated Adviser and Sole BrokerLSE:AGYAllergy Therapeutics Plc
04/07/202415:22RNS Regulatory NewsAllergy Therapeutics PLC Launch of new Company Long Term Incentive PlanLSE:AGYAllergy Therapeutics Plc
27/06/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Non-Executive DirectorLSE:AGYAllergy Therapeutics Plc
10/06/202410:36Alliance NewsAlliance NewsAllergy Therapeutics welcomes peanut allergy vaccine trial resultsLSE:AGYAllergy Therapeutics Plc
03/06/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Successful meetings with Paul Ehrlich InstitutLSE:AGYAllergy Therapeutics Plc
31/05/202408:00RNS Non-RegulatoryAllergy Therapeutics PLC Allergy Therapeutics presents findings at EAACILSE:AGYAllergy Therapeutics Plc
07/05/202421:22Alliance NewsAlliance NewsTRADING UPDATES: Abingdon Health buys IVDeology HoldingsLSE:AGYAllergy Therapeutics Plc
07/05/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Further detail from G306 Phase III field trialLSE:AGYAllergy Therapeutics Plc
03/04/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Director ResignationLSE:AGYAllergy Therapeutics Plc
27/03/202417:13Alliance NewsAlliance NewsEARNINGS AND TRADING: Solid State ups outlook; Quartix trading in lineLSE:AGYAllergy Therapeutics Plc
27/03/202408:00RNS Regulatory NewsAllergy Therapeutics PLC Interim Results for six months ended 31 Dec 2023LSE:AGYAllergy Therapeutics Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AGY

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
NEXI
Nexi S.p.A
BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
TIT
Telecom Italia
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
CPR
Davide Campari
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
BC
Brunello Cucinelli
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network